Dale W.

Dale W. is a senior director at Pfizer with extensive experience in pharmaceutics, solid state chemistry, and material properties, specializing in drug product design and development. Currently, Dale leads the formulation and process design group, overseeing oral dosage form development from first-in-human trials to commercialization. Throughout their career at Pfizer, they have contributed to various drug development programs across multiple therapeutic areas, including oncology and infectious diseases, and played a crucial role in the rapid development and commercialization of Paxlovid. Dale holds a PhD in Physical Chemistry from Clarkson University.